Lucknow, India

Chandeshwar Nath

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chandeshwar Nath. Retrieved from https://idiyas.com/inventor/chandeshwar-nath-odpu4nsg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,570 
Other
 patents

Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Chandeshwar Nath

Introduction

Chandeshwar Nath is a notable inventor based in Lucknow, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds with potential therapeutic applications.

Latest Patents

One of his key patents is titled "Oxy substituted chalcones as antihyperglycemic and antidyslipidemic agents." This invention provides appropriately substituted chalcones, represented by a specific structural formula. The compounds exhibit significant antidiabetic effects in various animal models, indicating their potential for further exploitation. Chandeshwar Nath holds 1 patent in this area.

Career Highlights

Chandeshwar Nath has dedicated his career to research and innovation in the pharmaceutical field. His work focuses on developing new compounds that can address critical health issues, particularly diabetes and related metabolic disorders.

Collaborations

He has collaborated with notable colleagues, including Ram Pratap and Mavurapu Satyanarayana, to advance his research and patent applications.

Conclusion

Chandeshwar Nath's contributions to the field of medicinal chemistry highlight his innovative spirit and commitment to improving health outcomes through scientific research. His work continues to pave the way for future advancements in the treatment of diabetes and related conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…